On CNBC's "Mad Money Lightning Round," Jim Cramer said he is intrigued about Anavex Life Sciences Corp AVXL because Biogen Inc BIIB data doesn't look that good. He sees it as a real spec, but he would stick with it.
Cramer is done with Chinese IPOs. He would sell Nio Inc - ADR NIO.
He doesn't understand a short position in Upstart Holdings Inc UPST.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
